3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
32
Carcinoma, Intraductal, Noninfiltrating
7
Breast Carcinoma In Situ
4
Prostatic Neoplasms
2
Ovarian Neoplasms
2
Neoplasms
2
Infertility
2
Breast Neoplasms, Male
2
Breast Diseases
2
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Precancerous Conditions
1
Polycystic Ovary Syndrome
1
Pancreatic Neoplasms
1
Pancreatic Cyst
1
Neoplasms by Site
1
Hypogonadism
1
Hot Flashes
1
Hereditary Sensory and Autonomic Neuropathies
1
Head and Neck Neoplasms
1
Endometrial Neoplasms
1
Carcinoma, Ductal
1
Anovulation
1
Anatomic Stage III Breast Cancer AJCC v8
1
Interventions
talimogene laherparepvec
1
exemestane
1
Tamoxifen
1
Surgical Procedures, Operative
1
Specimen Handling
1
Paclitaxel
1
Mastectomy, Segmental
1
Letrozole
1
Brachytherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinoma, Ductal
×
Tamoxifen
×
90 days
×
Clear all
NCT07499999
2026-03-30
BabyTEARS
Dana-Farber Cancer Institute
Phase 2
Not yet recruiting
140 enrolled